SEC Form 4 · accession 0001127602-16-043917
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gayle E Wilson
Director
Period of report
Feb 26, 2016
Accepted (ET)
Feb 29, 2016 · 5:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2016 | M | 6,650 | $20.705 | A | 110,523 | D | |
| Common Stock | Feb 26, 2016 | S | 6,650 | $90.61 | D | 103,873 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F1 | $20.705 | Feb 26, 2016 | M | 6,650 | D | — | May 9, 2017 | Common Stock | 6,650 | 33,350 | D |
Explanation of responses
- F1Options are 100% vested on the date of grant.